Abstract
In advanced esophageal cancer, 90% of patients have dysphagia as their predominant symptom. Although chemotherapy has demonstrated benefits in curing esophageal cancer, the only data on appropriate palliative treatment are from small, retrospective trials. The Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia [NCT00193882] aims to establish effective and minimally toxic treatments for relief of dysphagia in advanced esophageal cancer and to determine the effects of common cancer treatments on quality of life.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
